Back to Journals » International Journal of Nanomedicine » Volume 7

Degradation and osteogenic potential of a novel poly(lactic acid)/nano-sized β-tricalcium phosphate scaffold

Authors Cao L, Duan PG, Wang HR, Li XL, Yuan FL, Fan ZY, Li SM, Dong J

Received 14 September 2012

Accepted for publication 27 October 2012

Published 28 November 2012 Volume 2012:7 Pages 5881—5888

DOI https://doi.org/10.2147/IJN.S38127

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 5

Lu Cao,1,2 Ping-Guo Duan,1,2 Hui-Ren Wang,1,2 Xi-Lei Li,1,2 Feng-Lai Yuan,3 Zhong-Yong Fan,4 Su-Ming Li,5 Jian Dong1,2

1
Department of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China; 2State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China; 3Affiliated Third Hospital of Nantong University, Wuxi, Jiangsu, China; 4Department of Materials Science, Fudan University, Shanghai, China; 5Max Mousseron Institute on Biomolecules, Montpellier I University, Montpellier, France

Abstract: The purpose of this study was to investigate the influence of nano-sized β-tricalcium phosphate (β-TCP) on the biological performance of poly (lactic acid) (PLA) composite scaffolds by using in vitro degradation and an in vivo model of heterotopic bone formation. Nano-sized βTCP (nβ-TCP) was prepared with a wet grinding method from micro-sized β-TCP (mβ-TCP), and composite scaffolds containing 0, 10, 30, or 50 wt% nβ-TCP or 30 wt% mβ -TCP were generated using a freeze-drying method. Degradation was assessed by monitoring changes in microstructure, pH, weight, and compressive strength over a 26-week period of hydrolysis. Composite scaffolds were processed into blocks, and implanted into muscular pockets of rabbits after loading with recombinant human bone morphogenetic protein-2 (rhBMP-2). New bone formation was evaluated based on histological and immunohistochemical analysis 2, 4, and 8 weeks after implantation. The in vitro results indicated that the buffering effect of nβ-TCP was stronger than mβ-TCP, which was positively correlated with the content of nβ-TCP. The in vivo findings demonstrated that nβ-TCP enhanced the osteoconductivity of the scaffolds. Although composite scaffolds containing 30% nβ-TCP exhibited similar osteoconductivity to 50% nβ-TCP, they had better mechanical properties than the 50% nβ-TCP scaffolds. This study supports the potential application of a composite scaffold containing 30% nβ-TCP as a promising scaffold for bone regeneration.

Keywords: poly (lactic acid), β-tricalcium phosphate, biodegradation, porous scaffold, bone regeneration

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Readers of this article also read:

Bone repair by periodontal ligament stem cell-seeded nanohydroxyapatite-chitosan scaffold

Ge S, Zhao N, Wang L, Yu M, Liu H, Song A, Huang J, Wang G, Yang P

International Journal of Nanomedicine 2012, 7:5405-5414

Published Date: 10 October 2012

Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity

Leite EA, Souza CM, Carvalho-Júnior AD, Coelho LG, Lana AM, Cassali GD, Oliveira MC

International Journal of Nanomedicine 2012, 7:5259-5269

Published Date: 9 October 2012

Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies

Monteiro LM, Lione VF, do Carmo FA, do Amaral LH, da Silva JH, Nasciutti LE, Rodrigues CR, Castro HC, de Sousa VP, Cabral LM

International Journal of Nanomedicine 2012, 7:5175-5182

Published Date: 28 September 2012

Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release

Chen M, Le DQ, Hein S, Li P, Nygaard JV, Kassem M, Kjems J, Besenbacher F, Bünger C

International Journal of Nanomedicine 2012, 7:4285-4297

Published Date: 3 August 2012

Nanofiber composites containing N-heterocyclic carbene complexes with antimicrobial activity

Elzatahry AA, Al-Enizi AM, Elsayed EA, Butorac RR, Al-Deyab SS, Wadaan MAM, Cowley AH

International Journal of Nanomedicine 2012, 7:2829-2832

Published Date: 7 June 2012

PLLA-PEG-TCH-labeled bioactive molecule nanofibers for tissue engineering

Chen J, Zhou B, Li Q, Ouyang J, Kong J, Zhong W, Xing MM

International Journal of Nanomedicine 2011, 6:2533-2542

Published Date: 21 October 2011

Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles

Chen Y, Wan Y, Wang Y, Zhang H, Jiao Z

International Journal of Nanomedicine 2011, 6:2321-2326

Published Date: 18 October 2011

Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin

Ahangari Cohan R, Madadkar-Sobhani A, Khanahmad H, Roohvand F, Aghasadeghi MR, Hedayati MH, Barghi Z, Shafiee Ardestani M, Nouri Inanlou D, Norouzian D

International Journal of Nanomedicine 2011, 6:1217-1227

Published Date: 15 June 2011